SUBSCRIBE
SUBSCRIBE

Preclinical

Two Bay Area Diagnostic Companies Win Amgen's Golden Ticket
Drug Development
Amgen Releases Secret Data on Three Failed Studies to Confirm Findings in High Profile Journals
February 4, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
NovaTarg Therapeutics Aims to Reveal First Drug Candidates for Type 2 Diabetes, Kidney Disease in 2016
December 10, 2015
 · 
3 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Regeneron Scientists Discover Key to Why Some People’s Muscles Suddenly Turn into Bone
September 3, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Johnson & Johnson HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400
July 6, 2015
 · 
3 min read
Job Trends
Celladon Lays Off More Staff, Considers Liquidation in Wake of Gene Therapy Failure
June 26, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Despite Promising AbbVie Partnerships, Neurocrine Biosciences Halts Two Clinical Trials
June 9, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Celgene CEO: Partnerships Bear Fruit to Four New Compounds
May 11, 2015
 · 
3 min read
EXCLUSIVE: Navidea CEO Tells BioSpace New Cancer Treatment Will See More Trial Data in 2015
Drug Development
EXCLUSIVE: Navidea CEO Tells BioSpace New Cancer Treatment Will See More Trial Data in 2015
April 28, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Bayer HealthCare Strikes Deal With Mission Bay Incubator Tenant Aronora
February 24, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Despite CEO’s Comments, Experimental Sarepta Drug Protects Lab Monkeys From Ebola
February 11, 2015
 · 
5 min read
Load More
PRESS RELEASES
Press Releases
HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
June 24, 2026
 · 
4 min read
Press Releases
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
June 22, 2026
 · 
7 min read
Press Releases
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
June 22, 2026
 · 
5 min read
Press Releases
Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
June 21, 2026
 · 
8 min read
Press Releases
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
June 19, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
June 18, 2026
 · 
7 min read
Press Releases
Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD
June 18, 2026
 · 
6 min read
Press Releases
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
June 16, 2026
 · 
7 min read
Press Releases
Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026
June 15, 2026
 · 
3 min read
Press Releases
Ethyreal Bio Presents First Preclinical Data on ETHY-001 at ENDO 2026, Demonstrating Complete Blockade of Autoantibody Activation of TSHR and Differentiated Activity in TED
June 15, 2026
 · 
5 min read
Press Releases
Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model
June 15, 2026
 · 
7 min read
Press Releases
Preclinical Data for OPKO Biologics’ OPK8801001 in Acromegaly Presented at ENDO 2026
June 15, 2026
 · 
4 min read
Press Releases
Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity
June 12, 2026
 · 
2 min read
Press Releases
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses
June 12, 2026
 · 
3 min read
Press Releases
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
June 12, 2026
 · 
4 min read
Press Releases
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
June 11, 2026
 · 
2 min read
Press Releases
JW Pharmaceutical Presents Preclinical Results and Global Development Strategy for DDC-02, a Novel Therapeutic Candidate for Rare Neurodevelopmental Disorders
June 11, 2026
 · 
4 min read
Press Releases
Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026
June 11, 2026
 · 
3 min read
Press Releases
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026
 · 
5 min read
Press Releases
HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen
June 10, 2026
 · 
3 min read
Load More